JFS Wealth Advisors’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13
Closed -$309 1954
2025
Q1
$309 Sell
13
-4
-24% -$95 ﹤0.01% 1812
2024
Q4
$360 Sell
17
-40
-70% -$1.05K ﹤0.01% 1813
2024
Q3
$1.84K Buy
57
+30
+111% +$886 ﹤0.01% 1525
2024
Q2
$643 Hold
27
﹤0.01% 1766
2024
Q1
$806 Buy
27
+9
+50% +$282 ﹤0.01% 1705
2023
Q4
$576 Buy
18
+7
+64% +$203 ﹤0.01% 1776
2023
Q3
$322 Sell
11
-19
-63% -$683 ﹤0.01% 1808
2023
Q2
$1.35K Buy
30
+23
+329% +$878 ﹤0.01% 1511
2023
Q1
$242 Hold
7
﹤0.01% 1806
2022
Q4
$195 Buy
7
+5
+250% +$132 ﹤0.01% 1834
2022
Q3
$0 Buy
+2
New +$64 ﹤0.01% 1911
2022
Q2
Sell
-12
Closed -$1K 1917
2022
Q1
$1K Buy
12
+8
+200% +$396 ﹤0.01% 1723
2021
Q4
$0 Buy
+4
New +$186 ﹤0.01% 1870

Other funds holding SGRY

JFS Wealth Advisors's SGRY Position: Q2 2025 in Review

JFS Wealth Advisors sold out of Surgery Partners (SGRY) in Q2 2025, closing a stake of 13 shares — an estimated $309 sold.

JFS Wealth Advisors first reported a position in SGRY in Q4 2021 and held it in 13 quarters. The position peaked at $1.84K in Q3 2024. 201 funds tracked by Wall St. Rank hold SGRY as of Q2 2025.

  • JFS Wealth Advisors reported no remaining Surgery Partners position as of Q2 2025 after selling out during the quarter.
  • JFS Wealth Advisors sold 13 Surgery Partners shares in Q2 2025, an estimated $309.
  • JFS Wealth Advisors first reported a position in Surgery Partners in Q4 2021 and held it in 13 quarters.
  • JFS Wealth Advisors's Surgery Partners position peaked at $1.84K in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2025.

Based on JFS Wealth Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.